Radiopharmacy Practice Test

The maximum activity for a Tc-99m sestamibi dose sent in bulk from the manufacturer is 150 mCi. This limit is established to ensure the safety and stability of the radiopharmaceutical during transport and handling. Regulatory guidelines, along with recommendations from various radiopharmaceutical manufacturers, dictate that doses above this level may pose an increased risk for radiation exposure to handling personnel and patients alike.

In bulk shipping scenarios, achieving high activity levels can complicate the preparation, administration, and quality control processes. Keeping the maximum activity at 150 mCi not only aligns with safe handling practices but also ensures that the pharmaceutical remains viable and effective by reducing the risk of radiation dose to those involved in its preparation and distribution. This allows for the adequate administration of the radiopharmaceutical in a clinical setting while complying with safety standards established by health authorities.

Lower activity levels above or below this maximum may disrupt workflow and storage requirements, emphasizing the importance of staying within the established limits for radiopharmaceuticals when they are shipped in bulk.